Standard pathology tests outperform molecular subtyping in bladder cancer
While trying to develop a comparatively easy, inexpensive way to give physicians and their patients…
Browsing: GU Cancers
Anti-CTLA-4 antibody tremelimumab shows efficacy in patients with metastatic bladder cancer
Treatment with the investigational anti-CTLA-4 agent tremelimumab showed clinical responses in patients with pretreated metastatic…
Cancer patients are at higher risk of dying from heart disease and stroke
More than one in ten cancer patients do not die from their cancer but from…
Anthrax may be the next tool in the fight against bladder cancer
Anthrax may soon help more patients with bladder cancer which is one of the most…
Oxygen in hyperbaric chamber provides relief after radiotherapy
Hyperbaric oxygen therapy (HBOT) can relieve self-reported symptoms and side-effects of radiotherapy against cancer in…
ESMO 2019: Adding immunotherapy to chemotherapy prolongs progression free survival in bladder cancer
Patients with metastatic urothelial cancer have longer progression free survival when treated with first-line immunotherapy…
#ANZUP19 Highlights from Brisbane
While we were set a very high benchmark on the back of last year’s ASM,…
ASCO 2019: The eight biggest stories on anticancer agents
Here is ecancer’s speedy recap on the presentations from the 2019 American Society of Clinical…
From urine samples to precision medicine in bladder cancer through 3-D cell culture
A research collaborative led by scientists from institutions in Japan including Tokyo University of Agriculture…
Bladder cancer: how we used a common cold virus to defeat it
Hardev Pandha, University of Surrey Non-muscle invasive bladder cancer is the tenth most common cancer…